AC
DGX icon

AXQ Capital’s Quest Diagnostics DGX Stock Holding History

AXQ Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360K Buy
+1,697
New +$333K 0.04% 572
2026
Q1 		– Sell
-2,550
Closed -$443K – 1056
2025
Q4 		$443K Buy
2,550
+485
+23% +$88.3K 0.1% 323
2025
Q3 		$394K Buy
2,065
+922
+81% +$164K 0.15% 246
2025
Q2 		$205K Sell
1,143
-4,254
-79% -$739K 0.07% 461
2025
Q1 		$913K Buy
+5,397
New +$887K 0.37% 69
2024
Q1 		– Sell
-5,400
Closed -$745K – 679
2023
Q4 		$745K Buy
+5,400
New +$710K 0.2% 181

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

AXQ Capital's DGX Position: Q2 2026 in Review

AXQ Capital opened a new position in Quest Diagnostics (DGX) in Q2 2026: 1,697 shares worth $360K. The stake represents 0.04% of the portfolio and ranks #572 among its holdings. This is a return to the name: AXQ Capital previously reported a position in DGX as recently as Q4 2025.

AXQ Capital first reported a position in DGX in Q4 2023 and has held it in 6 quarters since. The position peaked at $913K in Q1 2025. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • AXQ Capital held 1,697 shares of Quest Diagnostics worth $360K as of Q2 2026.
  • Quest Diagnostics was a new AXQ Capital position in Q2 2026.
  • Quest Diagnostics made up 0.04% of AXQ Capital's portfolio in Q2 2026, its #572 holding.
  • AXQ Capital first reported a position in Quest Diagnostics in Q4 2023 and has held it in 6 quarters since.
  • AXQ Capital's Quest Diagnostics position peaked at $913K in Q1 2025.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.